Related Experiment Video
Updated: Oct 27, 2025
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Antimicrobial peptides as potential therapeutics for breast cancer
Shahin Aghamiri1, Farshid Zandsalimi2, Pourya Raee3
1Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Breast cancer is the most common and deadliest cancer in women worldwide. Although notable advances have been achieved in the treatment of breast cancer, the overall survival rate of metastatic breast cancer patients is still considerably low due to the development of resistance to breast cancer chemotherapeutic agents and the non-optimal specificity of the current generation of cancer medications. Hence, there is a growing interest in the search for alternative therapeutics with novel anticancer mechanisms. Recently, antimicrobial peptides (AMPs) have gained much attention due to their cost-effectiveness, high specificity of action, and robust efficacy. However, there are no clinical data available about their efficacy. This warrants the increasing need for clinical trials to be conducted to assess the efficacy of this new class of drugs. Here, we will focus on the recent progress in the use of AMPs for breast cancer therapy and will highlight their modes of action. Finally, we will discuss the combination of AMP-based therapeutics with other breast cancer therapy strategies, including nanotherapy and chemotherapy, which may provide a potential avenue for overcoming drug resistance.
Insights
Antimicrobial peptides (AMPs) show promise as novel breast cancer therapies due to their specificity and efficacy. Clinical trials are needed to confirm their effectiveness and explore combinations with other treatments to overcome drug resistance.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Background:
- Breast cancer remains a leading cause of death in women globally.
- Current treatments face challenges like drug resistance and limited specificity, impacting survival rates for metastatic disease.
- Novel therapeutic strategies are urgently needed to improve outcomes.
Purpose of the Study:
- To review recent advancements in using antimicrobial peptides (AMPs) for breast cancer therapy.
- To elucidate the mechanisms of action of AMPs against breast cancer cells.
- To explore the potential of combining AMP-based therapeutics with other strategies like nanotherapy and chemotherapy.
Main Methods:
- Literature review of preclinical and emerging research on AMPs in breast cancer.
- Analysis of reported modes of action for various AMPs.
- Discussion of synergistic effects and combination strategies.
Main Results:
- Antimicrobial peptides (AMPs) demonstrate high specificity and efficacy against cancer cells.
- AMPs offer a cost-effective alternative with novel anticancer mechanisms.
- No clinical data currently exists, highlighting the need for clinical trials.
Conclusions:
- AMPs represent a promising class of therapeutics for breast cancer treatment.
- Further clinical investigation is essential to validate AMP efficacy and safety.
- Combination therapies involving AMPs may offer a viable approach to overcome treatment resistance.
Related Concept Videos
01:23Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:38Mitogens and the Cell Cycle